Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis

: ilustraciones, gráficos, tablas ; 28 cm.

Autores:
Vélez Bermúdez, Claudia Patricia
Torres Leal, Lizdiany
Tipo de recurso:
Fecha de publicación:
2024
Institución:
Fundación Universitaria del Área Andina
Repositorio:
Repositorio Digital Areandina
Idioma:
spa
OAI Identifier:
oai:digitk.areandina.edu.co:areandina/6267
Acceso en línea:
https://digitk.areandina.edu.co/handle/areandina/6267
Palabra clave:
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id RAreandin2_4b2c416d6360a3cce9f8320ecc0673fb
oai_identifier_str oai:digitk.areandina.edu.co:areandina/6267
network_acronym_str RAreandin2
network_name_str Repositorio Digital Areandina
repository_id_str
dc.title.spa.fl_str_mv Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
title Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
spellingShingle Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
title_short Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
title_full Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
title_fullStr Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
title_full_unstemmed Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
title_sort Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y Metaanálisis
dc.creator.fl_str_mv Vélez Bermúdez, Claudia Patricia
Torres Leal, Lizdiany
dc.contributor.advisor.none.fl_str_mv Delgado, José Elías
dc.contributor.author.none.fl_str_mv Vélez Bermúdez, Claudia Patricia
Torres Leal, Lizdiany
description : ilustraciones, gráficos, tablas ; 28 cm.
publishDate 2024
dc.date.available.none.fl_str_mv 2024-04-30
2025-04-11T19:56:42Z
dc.date.issued.none.fl_str_mv 2024-11-09
dc.date.accessioned.none.fl_str_mv 2025-04-11T19:56:42Z
dc.type.none.fl_str_mv Trabajo de grado - Especialización
dc.type.content.none.fl_str_mv Text
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/TM
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv https://digitk.areandina.edu.co/handle/areandina/6267
url https://digitk.areandina.edu.co/handle/areandina/6267
dc.language.iso.none.fl_str_mv spa
language spa
dc.relation.references.none.fl_str_mv Gobierno de Estados Unidos. Instituto Nacional de Cáncer. https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer. 2024. Diccionario Nacional de Cáncer. 2. OMS. Organización Mundial de la Salud. https://www.paho.org/es/temas/coronavirus. 2024. Coronavirus. 3. OMS. Organización Mundial de la Salud - OPS. Organización Panamericana de la Salud. Módulo de Principios de Epidemiología para el Control de Enfermedades (MOPECE). Segunda edición. Washington D.C; 2011. 4. NIH. Biblioteca Nacional de Medicina de Estados Unidos. 2024. Medline Plus. 5. OMS. Organización Mundial de la Salud - OPS. Organización Panamericana de la Salud. https://www.paho.org/es/temas/determinantes-sociales-salud. 2024. Determinantes sociales de la salud. 6. OMS. Organización Mundial de la Salud - OPS. Organización Panamericana de la Salud. BIREME. Biblioteca virtual en salud. 2024. DeCS MeSH Descriptores en Ciencias de la Salud. 7. Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, Anderson EJ, Weigel A, Monroe ML, Reeg L, Bye E, Sosin DM, Muse A, Bennett NM, Billing LM, Sutton M, Talbot HK, McCaffrey K, Pham H, Patel K, Whitaker M, McMorrow M HFCN surveillance team. RF for SC 19 in ChildrenO 2022. Risk Factors for Severe COVID-19 in Children. Pediatrics [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/34686570/ 8. Bai Y, Gao L, Wang X, Zhong L, Li J, Ding S, Zheng Y, Liu J, Cui Y, Wang L, Han M, Liu J, Jiang X, Jiang M, Li J, Chen N, Shang Y, Zhou H, Xu Y, Lu G, Chen X, Xu J, Fan Q, Tang Y, Wu J, Li C, Yang X, Chen C, Yang Y, Wing-Kin Wong G, Shen A, Wang T, Jin R, SK. Epidemiological characteristics and clinical manifestations of pediatric patients with COVID‐19 in China. A multicenter retrospective study. Pediatr Investig [Internet]. 2021;5(3). Available from: https://pubmed.ncbi.nlm.nih.gov/34540320/ 9. González-García N, Miranda-Lora AL, Garduño-Espinosa J, Granados-Riverón JT, MéndezGalván JF, Nieto-Zermeño J, et al. Heterogeneidad internacional en las tasas de mortalidad pediátrica por COVID-19. Bol Med Hosp Infant Mex [Internet]. 2021;78(1):24–8. Available from: http://www.scielo.org.mx/scielo.php?pid=S1665- 11462021000100024&script=sci_abstract 10. Oliveira EA, Colosimo EA, Simões e Silva AC, Mak RH, Martelli DB, Silva LR, et al. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database. Lancet Child Adolesc Health. 2021;5(8):559–68. 11. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review. 2020; Available from: https://jamanetwork.com/
Umakanthan S, Sahu P, Ranade A V., Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–8. 13. Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, et al. The Effect of Prior AngiotensinConverting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 ( COVID-19 ) Susceptibility and Outcome : A Systematic Review and Metaanalysis. Clinical Infectious Diseases [Internet]. 2021;2019(2):901–13. Available from: https://pubmed.ncbi.nlm.nih.gov/33079200/ 14. Morales Fernández JA, Wong Chew RM. Generalidades, aspectos clínicos y de prevención sobre COVID-19: México y Latinoamérica. Universitas Médica. 2021 Jul;62(3). 15. Santos-lópez G, Cortés-hernández P, Reyes-leyva VV ruiz J. SARS-CoV-2 : generalidades , origen y avances en el tratamiento. Gac Med Mex [Internet]. 2021;157:88–93. Available from: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/ 16. Wang H, Li X, Li T, Zhang S, Wang L, Wu X, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology and Infectious Diseases. 2020;39(9):1629–35. 17. Belasco AGS, Fonseca CD da. Coronavirus 2020. Rev Bras Enferm. 2020 Mar;73(2). 18. Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol [Internet]. 2020;41. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833675/pdf/main.pdf 19. Asociación Colombiana de Infectología, ACIN; Instituto de Evaluación Tecnológica en Salud IETS. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio [Internet]. 2020; Available from: https://www.revistainfectio.org/index.php/infectio/article/view/851/0 20. OMS. Organización Mundial de la Salud. Manejo clínico de la COVID-19. Orientaciones evolutivas 25 de Enero de 2021. [Internet]. 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/340629/WHO-2019-nCoV-clinical-2021.1- spa.pdf 21. OMS. Síndrome inflamatorio multisistémico en niños y adolescentes con COVID-19. Informe científico. 2020. p. 1–3. 22. Dumoy J. Los factores de riesgo. Rev Cubana Med Gen Integr [Internet]. 1999;v.15 n.4. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21251999000400018 23. Nachega JB, Sam-Agudu NA, MacHekano RN, Rabie H, Van Der Zalm MM, Redfern A, et al. Assessment of Clinical Outcomes among Children and Adolescents Hospitalized with COVID-19 in 6 Sub-Saharan African Countries. JAMA Pediatr. 2022 Mar 1;176(3):E216436.
AAP. Hispanic , Black youths represent disproportionate percent of COVID hospitalizations. 2022;(August 2021):2021–2. 25. OMS. Organización Mundial de la Salud. Seguimiento de las variantes del SARS-CoV-2 [Internet]. 2022. Available from: https://www.who.int/es/activities/tracking-SARS-CoV-2- variants 26. Marks KJ, Whitaker M, Anglin O, Milucky J, Patel K, Pham H, Chai SJ, Kirley PD, Armistead I, McLafferty S, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Weigel A, Henderson J, Nunez VT, Como-Sabetti K, Lynfield R, Ropp SL, Smelser C, Barney GR, Muse A, HF. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022. 2022. MMWR Morb Mortal Wkly Rep [Internet]. 71(7):271-. Available from: https://pubmed.ncbi.nlm.nih.gov/35176003/ 27. WHO. COVID-19 weekly epidemiological update [Internet]. World Health Organization. 2021. Available from: https://www.who.int/publications/m/item/covid-19-weeklyepidemiological-update 28. World Health Organization (WHO). Coronavirus Disease 2019 Situation Report 52 12th March. World Health Organization [Internet]. 2020;2019(August):2633. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 29. AAP. Children and COVID-19: State-Level Data Report. 2022. American Academy of Pediatrics. Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19- infections/children-and-covid-19-state-level-data-report/ 30. Olivar-López V, Leyva-Barrera A, López-Martínez B, Parra-Ortega I, Márquez-González H. Clinical risk profile associated with SARS-CoV-2 infection and complications in the emergency area of a pediatric COVID-19 center. Bol Med Hosp Infant Mex. 2020;77(5):221–7. 31. Shi DS, Whitaker M, Marks KJ et al. CDC. MMWR .Morbidity and Mortality Weekly Report. 2022. Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. 32. Hannah Ritchie, Edouard Mathieu, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-Ospina, Joe Hasell, Bobbie Macdonald DB and MR. “Coronavirus Pandemic (COVID-19).” 2020. 33. Delahoy MJ UDWM et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep 2021. 2021. 34. Fox Maggie. CNN en español. Casos de covid-19 en niños aumentan casi un 240% desde julio, según asociación de pediatras. Available from: https://cnnespanol.cnn.com/2021/09/13/covid-19-ninos-aumento-240-trax/ 35. FDA. 2021. La FDA autoriza vacuna contra el COVID-19 de Pfizer-BioNTech para uso de emergencia en niños de 5 a 11 años de edad [Internet]. Available from:
https://www.fda.gov/news-events/press-announcements/la-fda-autoriza-vacuna-contra-elcovid-19-de-pfizer-biontech-para-uso-de-emergencia-en-ninos-de-5-11 36. OMS. Organización Mundial de la Salud. La vacuna de Pfizer-BioNTech (BNT162b2) contra la COVID-19: lo que debe saber [Internet]. Available from: https://www.who.int/es/news-room/feature-stories/detail/who-can-take-the-pfizer-biontechcovid-19--vaccine-what-you-need-to-know 37. Ferreira González I, Urrútia G, Alonso-Coello P. Systematic reviews and meta-analysis: Scientific rationale and interpretation. Rev Esp Cardiol. 2011;64(8):688–96. 38. Escrig Sos VJ, Llueca Abella JA, Granel Villach L, Bellver Oliver M. Metaanálisis: una forma básica de entender e interpretar su evidencia. Revista de Senología y Patología Mamaria. 2021;34(1):44–51. 39. SERGAS SG de SP. Epidat 4: Ayuda de Muestreo. Octubre 2014. 2014; Available from: https://www.sergas.es/Saude-publica/Documents/1931/3-Ayuda Muestreo.pdf 40. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. 41. Elmagarmid A, Fedorowicz Z, Hammady H, Ilyas I, Khabsa M, Ouzzani M. Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, and Ahmed Elmagarmid. Rayyan — a web and mobile app for systematic reviews. Systematic Reviews (2016) 5:210, DOI: 10.1186/s13643-016-0384-4. Abstracts of the 22nd Cochrane Colloquium. 2016. 42. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ [Internet]. 2021;372. Available from: http://www.prismastatement.org/documents/PRISMA_2020_expanded_checklist.pdf 43. GA Wells, B Shea, D O’Connell, J Peterson, V Welch, M Losos PT. The Ottawa Hospital. Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 44. Sterne J, Hernán M, McAleenan A, Reeves B HJ. Assessing risk of bias in a nonrandomized study. In: Cochrane Handbook for Systematic Reviews of Interventions [Internet]. 2017. Available from: https://training.cochrane.org/handbook/current/chapter-25 45. Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 2021 May 1;5(5):323–31. 46. Hendler JV, Miranda do Lago P, Müller GC, Santana JC, Piva JP, Daudt LE. Risk factors for severe COVID-19 infection in Brazilian children. Brazilian Journal of Infectious Diseases. 2021 Nov 1;25(6).
Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying Medical Conditions Associated with Severe COVID-19 Illness among Children. JAMA Netw Open. 2021; 48. Martin B, Dewitt PE, Russell S, Anand A, Bradwell KR, Bremer C, et al. Characteristics, Outcomes, and Severity Risk Factors Associated with SARS-CoV-2 Infection among Children in the US National COVID Cohort Collaborative. JAMA Netw Open. 2022; 49. Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021 Oct 1;22(10):1416–26. 50. Sousa BLA, Sampaio-Carneiro M, de Carvalho WB, Silva CA, Ferraro AA. Differences among Severe Cases of Sars-CoV-2, Influenza, and Other Respiratory Viral Infections in Pediatric Patients: Symptoms, Outcomes and Preexisting Comorbidities. Clinics (Sao Paulo). 2020;75:e2273. 51. Swann O V., Pollock L, Holden KA, Munro APS, Bennett A, Williams TC, et al. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves. Pediatr Res. 2023 Jan 1;93(1):207–16. 52. Tripathi S, Christison AL, Levy E, McGravery J, Tekin A, Bolliger D, et al. The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19. Hosp Pediatr. 2021 Nov 1;11(11):E297–307. 53. Choudhary R, Webber BJ, Womack LS, Dupont HK, Chiu SK, Wanga V, et al. Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19. Hosp Pediatr. 2022 Sep 1;12(9):760–71. 54. Farrar Mph DS, Hepburn CM, Drouin Mdcm O, El Tal T, Morin MP, Berard RA, et al. COVID-19 AND MIS-C HOSPITALIZATIONS IN CANADA 1 Demographic and Outcome Characteristics of Children Hospitalized with Acute COVID-19 versus Multisystem Inflammatory Syndrome in Children in Canada. Available from: https://doi.org/10.1101/2022.08.18.22278939 55. Fink EL, Robertson CL, Wainwright MS, Roa JD, Lovett ME, Stulce C, et al. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022 Mar 1;128:33–44. 56. Forrest CB, Burrows EK, Mejias A, Razzaghi H, Christakis D, Jhaveri R, et al. Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021. Pediatrics. 2022 Apr 1;149(4). 57. Prévost B, Retbi A, Binder-Foucard F, Borde A, Bruandet A, Corvol H, et al. Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France. 2022; Available from: https://hal.inria.fr/hal-03774138 58. Rao S, Jing N, Liu X, Lorman V, Maltenfort M, Schuchard J, et al. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-1 based cohort study from the RECOVER program 2 3. Available from: https://doi.org/10.1101/2022.09.26.22280364
Rhedin S, Lundholm C, Horne A, Smew AI, Osvald EC, Haddadi A, et al. Risk factors for multisystem inflammatory syndrome in children − A population-based cohort study of over 2 million children. 2022; Available from: https://doi.org/10.1016/j. 60. Ward JL, Harwood R, Smith C, Kenny S, Clark M, Davis PJ, et al. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med. 2022 Jan 1;28(1):193–200. 61. OMS. Organización Mundial de la Salud. “Vigilancia de salud pública en relación con la COVID-19, orientaciones provisionales, 16 de diciembre de 2020” [Internet]. Ginebra; 2020. p. 1–12. Available from: https://apps.who.int/iris/bitstream/handle/10665/338331/WHO-2019-nCoVSurveillanceGuidance-2020.8-spa.pdf 62. Choi JH, Choi SH, Yun KW. Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis. J Korean Med Sci. 2022;37(5). 63. Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, et al. Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021;41. 64. Bailey LC. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatr. 2020 Feb 1;175(2):176– 84. 65. Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020 Sep 1;4(9):653–61. 66. Uka A, Buettcher M, Bernhard-Stirnemann S, Fougère Y, Moussaoui D, Kottanattu L, et al. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study. Eur J Pediatr. 2022;181(3). 67. Preston LE, Chevinsky JR, Kompaniyets L, Lavery AM, Kimball A, Boehmer TK, et al. Characteristics and Disease Severity of US Children and Adolescents Diagnosed with COVID-19. JAMA Netw Open. 2021;4(4). 68. Huang SM, Wu CH, Yen TY, Wu ET, Wang CC, Lu FL, et al. Clinical characteristics and factors associated with severe COVID-19 in hospitalized children during the SARS-CoV-2 Omicron pandemic in Taiwan. Journal of Microbiology, Immunology and Infection. 2023; 69. Schober T, Caya C, Barton M, Bayliss A, Bitnun A, Bowes J, et al. Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalised children. BMJ Paediatr Open. 2022;6(1). 70. Chao JY, Derespina KR, Herold BC, Goldman DL, Aldrich M, Weingarten J, et al. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. Journal of Pediatrics. 2020;223.
. Ouldali N, Yang DD, Madhi F, Levy M, Gaschignard J, Craiu I, et al. Factors associated with severe SARS-CoV-2 infection. Pediatrics. 2021;147(3). 72. Wang Y, Zhu F, Wang C, Wu J, Liu J, Chen X, et al. Children Hospitalized With Severe COVID-19 in Wuhan. Pediatric Infectious Disease Journal. 2020;39(7). 73. Antoon JW, Grijalva CG, Thurm C, Richardson T, Spaulding AB, Ronald J Teufel II, et al. Factors Associated With COVID-19 Disease Severity in US Children and Adolescents. J Hosp Med. 2021;16(10). 74. Aparicio C. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and MetaAnalysis. medRxiv [Preprint]. 2024; 75. Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases [Internet]. 2021;103:246–56. Available from: https://doi.org/10.1016/j.ijid.2020.11.163 76. Lampidi S. Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population. . Eur J Pediatr. 2024 Jan; 77. Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR, Patel MM, et al. Incidence of Multisystem Inflammatory Syndrome in Children among US Persons Infected with SARSCoV-2. JAMA Netw Open. 2021;4(6). 78. Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA - Journal of the American Medical Association. 2021;325(11). 79. Rayner DG, Gou D, Chen JZX, Zhu E, Lin VW, Fu N. Prognostic factors for multisystem inflammatory syndrome in children: A systematic review and meta‐analysis. Acta Paediatr. 2024 Jan 10;113(1):39–47. 80. Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z. Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents—a Live Systematic Review and Meta-analysis. Vol. 10, Current Pediatrics Reports. 2022. 81. Lee EH, Kepler KL, Geevarughese A, Paneth-Pollak R, Dorsinville MS, Ngai S, et al. Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome. JAMA Netw Open. 2020;3(11). 82. Lona-Reyes JC, Paredes-Casillas P, Sepúlveda-Marrón J, Barrón-Balderas A, Cruz-Revilla R, Meza-López C, et al. Association of comorbidities and symptomatic infection and multisystemic inflammatory syndrome due to SARS-CoV-2 in children. Revista Chilena de Infectologia. 2021;38(5). 83. Zambrano LD, Ly KN, Link-Gelles R, Newhams MM, Akande M, Wu MJ, et al. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatric Infectious Disease Journal. 2022;41(11).
84. Auger N, Côté-Corriveau G, Kang H, Quach C, Lo E, Lee GE, et al. Multisystem inflammatory syndrome in 1.2 million children: longitudinal cohort study of risk factors. Pediatr Res. 2024;95(1). 85. AMM. Declaración de Helsinki. Principios éticos para las investigaciones médicas en seres humanos. 1964; Available from: https://www.wma.net/es/policies-post/declaracion-dehelsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/ 86. Gobierno de Colombia. Ministerio de Salud y Protección Social. Resolución 8430 de 1993. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION -8430-DE-1993.PDF
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.license.none.fl_str_mv Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.none.fl_str_mv 132 Paginas
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Fundación Universitaria del Areandina
dc.publisher.place.none.fl_str_mv colombia
dc.publisher.faculty.none.fl_str_mv Facultad de Ciencias de la Salud y del Deporte
dc.publisher.program.none.fl_str_mv Especialización en Epidemiología
publisher.none.fl_str_mv Fundación Universitaria del Areandina
institution Fundación Universitaria del Área Andina
bitstream.url.fl_str_mv https://digitk.areandina.edu.co/bitstreams/bc067c8a-e752-428e-9442-722c96d43f50/download
https://digitk.areandina.edu.co/bitstreams/17eaf464-af83-4c3d-b3ee-efa03bcb10ac/download
https://digitk.areandina.edu.co/bitstreams/6880f689-5c65-4442-a4b5-67bd7bc37c3d/download
https://digitk.areandina.edu.co/bitstreams/be5866df-002c-471f-8d5a-2c7aef154d21/download
https://digitk.areandina.edu.co/bitstreams/97b99bda-e013-4f19-9831-89c20dab1e40/download
https://digitk.areandina.edu.co/bitstreams/ea68d7aa-c1ee-4cf2-a515-513ecb92680d/download
https://digitk.areandina.edu.co/bitstreams/032b6458-18ea-4682-a384-0561aced4ba3/download
bitstream.checksum.fl_str_mv 4e145d859c743fbe343a529bf5209b69
1c39b35beba7e70388cd838e99d73d9b
73a5432e0b76442b22b026844140d683
2cc1235c6201572fe605a00e0af2773a
6108eeaa89a59c32ec0ddbb5ff94789b
4f375c9fb1bf163feffcd1689278eadf
015f682c8f750a2650e5e06dcf74fec1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Areandina
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1851058732443631616
spelling Delgado, José ElíasVélez Bermúdez, Claudia PatriciaTorres Leal, Lizdiany2025-04-11T19:56:42Z2024-04-302025-04-11T19:56:42Z2024-11-09https://digitk.areandina.edu.co/handle/areandina/6267: ilustraciones, gráficos, tablas ; 28 cm.Este documento presenta un trabajo de grado que consiste en una revisión sistemática y metaanálisis para identificar factores de riesgo asociados a la enfermedad severa por COVID-19 en menores de 18 años. Los autores buscaron y analizaron estudios observacionales publicados entre 2020 y 2022, evaluando factores sociodemográficos, epidemiológicos y clínicos. El objetivo principal fue determinar y cuantificar la asociación de estos factores con la gravedad de la enfermedad y el síndrome inflamatorio multisistémico en niños (MIS-C). Los resultados buscan informar la toma de decisiones clínicas y las políticas de salud pública dirigidas a la población pediátrica vulnerable.Tabla de contenido genérica Consideraciones generales.-- Pregunta de investigación.-- Objetivo de investigación.-- Justificación.-- Marco referencial.-- Metodología.-- Resultados.-- Conclusiones.-- Recomendaciones.-- Bibliografía.: ilustraciones, gráficos, tablas ; 28 cm.EspecializaciónEspecialista en Epidemiología132 Paginasapplication/pdfspaFundación Universitaria del AreandinacolombiaFacultad de Ciencias de la Salud y del DeporteEspecialización en EpidemiologíaTexto general de licencia/copyright EL AUTOR-ESTUDIANTE, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto, la obra es de su exclusiva autoría y tiene la titularidad sobre la misma. PARÁGRAFO: en caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL ESTUDIANTE-AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la Fundación Universitaria del Área Andina actúa como un tercero de buena fe.https://creativecommons.org/licenses/by-nc-nd/4.0/Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Factores de Riesgo Asociados a Enfermedad Severa por COVID-19 en Menores de 18 Años: Revisión Sistemática y MetaanálisisTrabajo de grado - EspecializaciónTextinfo:eu-repo/semantics/masterThesishttp://purl.org/redcol/resource_type/TMinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Gobierno de Estados Unidos. Instituto Nacional de Cáncer. https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer. 2024. Diccionario Nacional de Cáncer. 2. OMS. Organización Mundial de la Salud. https://www.paho.org/es/temas/coronavirus. 2024. Coronavirus. 3. OMS. Organización Mundial de la Salud - OPS. Organización Panamericana de la Salud. Módulo de Principios de Epidemiología para el Control de Enfermedades (MOPECE). Segunda edición. Washington D.C; 2011. 4. NIH. Biblioteca Nacional de Medicina de Estados Unidos. 2024. Medline Plus. 5. OMS. Organización Mundial de la Salud - OPS. Organización Panamericana de la Salud. https://www.paho.org/es/temas/determinantes-sociales-salud. 2024. Determinantes sociales de la salud. 6. OMS. Organización Mundial de la Salud - OPS. Organización Panamericana de la Salud. BIREME. Biblioteca virtual en salud. 2024. DeCS MeSH Descriptores en Ciencias de la Salud. 7. Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, Anderson EJ, Weigel A, Monroe ML, Reeg L, Bye E, Sosin DM, Muse A, Bennett NM, Billing LM, Sutton M, Talbot HK, McCaffrey K, Pham H, Patel K, Whitaker M, McMorrow M HFCN surveillance team. RF for SC 19 in ChildrenO 2022. Risk Factors for Severe COVID-19 in Children. Pediatrics [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/34686570/ 8. Bai Y, Gao L, Wang X, Zhong L, Li J, Ding S, Zheng Y, Liu J, Cui Y, Wang L, Han M, Liu J, Jiang X, Jiang M, Li J, Chen N, Shang Y, Zhou H, Xu Y, Lu G, Chen X, Xu J, Fan Q, Tang Y, Wu J, Li C, Yang X, Chen C, Yang Y, Wing-Kin Wong G, Shen A, Wang T, Jin R, SK. Epidemiological characteristics and clinical manifestations of pediatric patients with COVID‐19 in China. A multicenter retrospective study. Pediatr Investig [Internet]. 2021;5(3). Available from: https://pubmed.ncbi.nlm.nih.gov/34540320/ 9. González-García N, Miranda-Lora AL, Garduño-Espinosa J, Granados-Riverón JT, MéndezGalván JF, Nieto-Zermeño J, et al. Heterogeneidad internacional en las tasas de mortalidad pediátrica por COVID-19. Bol Med Hosp Infant Mex [Internet]. 2021;78(1):24–8. Available from: http://www.scielo.org.mx/scielo.php?pid=S1665- 11462021000100024&script=sci_abstract 10. Oliveira EA, Colosimo EA, Simões e Silva AC, Mak RH, Martelli DB, Silva LR, et al. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database. Lancet Child Adolesc Health. 2021;5(8):559–68. 11. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review. 2020; Available from: https://jamanetwork.com/Umakanthan S, Sahu P, Ranade A V., Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–8. 13. Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, et al. The Effect of Prior AngiotensinConverting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 ( COVID-19 ) Susceptibility and Outcome : A Systematic Review and Metaanalysis. Clinical Infectious Diseases [Internet]. 2021;2019(2):901–13. Available from: https://pubmed.ncbi.nlm.nih.gov/33079200/ 14. Morales Fernández JA, Wong Chew RM. Generalidades, aspectos clínicos y de prevención sobre COVID-19: México y Latinoamérica. Universitas Médica. 2021 Jul;62(3). 15. Santos-lópez G, Cortés-hernández P, Reyes-leyva VV ruiz J. SARS-CoV-2 : generalidades , origen y avances en el tratamiento. Gac Med Mex [Internet]. 2021;157:88–93. Available from: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/ 16. Wang H, Li X, Li T, Zhang S, Wang L, Wu X, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology and Infectious Diseases. 2020;39(9):1629–35. 17. Belasco AGS, Fonseca CD da. Coronavirus 2020. Rev Bras Enferm. 2020 Mar;73(2). 18. Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol [Internet]. 2020;41. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833675/pdf/main.pdf 19. Asociación Colombiana de Infectología, ACIN; Instituto de Evaluación Tecnológica en Salud IETS. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio [Internet]. 2020; Available from: https://www.revistainfectio.org/index.php/infectio/article/view/851/0 20. OMS. Organización Mundial de la Salud. Manejo clínico de la COVID-19. Orientaciones evolutivas 25 de Enero de 2021. [Internet]. 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/340629/WHO-2019-nCoV-clinical-2021.1- spa.pdf 21. OMS. Síndrome inflamatorio multisistémico en niños y adolescentes con COVID-19. Informe científico. 2020. p. 1–3. 22. Dumoy J. Los factores de riesgo. Rev Cubana Med Gen Integr [Internet]. 1999;v.15 n.4. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21251999000400018 23. Nachega JB, Sam-Agudu NA, MacHekano RN, Rabie H, Van Der Zalm MM, Redfern A, et al. Assessment of Clinical Outcomes among Children and Adolescents Hospitalized with COVID-19 in 6 Sub-Saharan African Countries. JAMA Pediatr. 2022 Mar 1;176(3):E216436.AAP. Hispanic , Black youths represent disproportionate percent of COVID hospitalizations. 2022;(August 2021):2021–2. 25. OMS. Organización Mundial de la Salud. Seguimiento de las variantes del SARS-CoV-2 [Internet]. 2022. Available from: https://www.who.int/es/activities/tracking-SARS-CoV-2- variants 26. Marks KJ, Whitaker M, Anglin O, Milucky J, Patel K, Pham H, Chai SJ, Kirley PD, Armistead I, McLafferty S, Meek J, Yousey-Hindes K, Anderson EJ, Openo KP, Weigel A, Henderson J, Nunez VT, Como-Sabetti K, Lynfield R, Ropp SL, Smelser C, Barney GR, Muse A, HF. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022. 2022. MMWR Morb Mortal Wkly Rep [Internet]. 71(7):271-. Available from: https://pubmed.ncbi.nlm.nih.gov/35176003/ 27. WHO. COVID-19 weekly epidemiological update [Internet]. World Health Organization. 2021. Available from: https://www.who.int/publications/m/item/covid-19-weeklyepidemiological-update 28. World Health Organization (WHO). Coronavirus Disease 2019 Situation Report 52 12th March. World Health Organization [Internet]. 2020;2019(August):2633. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 29. AAP. Children and COVID-19: State-Level Data Report. 2022. American Academy of Pediatrics. Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19- infections/children-and-covid-19-state-level-data-report/ 30. Olivar-López V, Leyva-Barrera A, López-Martínez B, Parra-Ortega I, Márquez-González H. Clinical risk profile associated with SARS-CoV-2 infection and complications in the emergency area of a pediatric COVID-19 center. Bol Med Hosp Infant Mex. 2020;77(5):221–7. 31. Shi DS, Whitaker M, Marks KJ et al. CDC. MMWR .Morbidity and Mortality Weekly Report. 2022. Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. 32. Hannah Ritchie, Edouard Mathieu, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-Ospina, Joe Hasell, Bobbie Macdonald DB and MR. “Coronavirus Pandemic (COVID-19).” 2020. 33. Delahoy MJ UDWM et al. Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb Mortal Wkly Rep 2021. 2021. 34. Fox Maggie. CNN en español. Casos de covid-19 en niños aumentan casi un 240% desde julio, según asociación de pediatras. Available from: https://cnnespanol.cnn.com/2021/09/13/covid-19-ninos-aumento-240-trax/ 35. FDA. 2021. La FDA autoriza vacuna contra el COVID-19 de Pfizer-BioNTech para uso de emergencia en niños de 5 a 11 años de edad [Internet]. Available from:https://www.fda.gov/news-events/press-announcements/la-fda-autoriza-vacuna-contra-elcovid-19-de-pfizer-biontech-para-uso-de-emergencia-en-ninos-de-5-11 36. OMS. Organización Mundial de la Salud. La vacuna de Pfizer-BioNTech (BNT162b2) contra la COVID-19: lo que debe saber [Internet]. Available from: https://www.who.int/es/news-room/feature-stories/detail/who-can-take-the-pfizer-biontechcovid-19--vaccine-what-you-need-to-know 37. Ferreira González I, Urrútia G, Alonso-Coello P. Systematic reviews and meta-analysis: Scientific rationale and interpretation. Rev Esp Cardiol. 2011;64(8):688–96. 38. Escrig Sos VJ, Llueca Abella JA, Granel Villach L, Bellver Oliver M. Metaanálisis: una forma básica de entender e interpretar su evidencia. Revista de Senología y Patología Mamaria. 2021;34(1):44–51. 39. SERGAS SG de SP. Epidat 4: Ayuda de Muestreo. Octubre 2014. 2014; Available from: https://www.sergas.es/Saude-publica/Documents/1931/3-Ayuda Muestreo.pdf 40. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. 41. Elmagarmid A, Fedorowicz Z, Hammady H, Ilyas I, Khabsa M, Ouzzani M. Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, and Ahmed Elmagarmid. Rayyan — a web and mobile app for systematic reviews. Systematic Reviews (2016) 5:210, DOI: 10.1186/s13643-016-0384-4. Abstracts of the 22nd Cochrane Colloquium. 2016. 42. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ [Internet]. 2021;372. Available from: http://www.prismastatement.org/documents/PRISMA_2020_expanded_checklist.pdf 43. GA Wells, B Shea, D O’Connell, J Peterson, V Welch, M Losos PT. The Ottawa Hospital. Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 44. Sterne J, Hernán M, McAleenan A, Reeves B HJ. Assessing risk of bias in a nonrandomized study. In: Cochrane Handbook for Systematic Reviews of Interventions [Internet]. 2017. Available from: https://training.cochrane.org/handbook/current/chapter-25 45. Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health. 2021 May 1;5(5):323–31. 46. Hendler JV, Miranda do Lago P, Müller GC, Santana JC, Piva JP, Daudt LE. Risk factors for severe COVID-19 infection in Brazilian children. Brazilian Journal of Infectious Diseases. 2021 Nov 1;25(6).Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying Medical Conditions Associated with Severe COVID-19 Illness among Children. JAMA Netw Open. 2021; 48. Martin B, Dewitt PE, Russell S, Anand A, Bradwell KR, Bremer C, et al. Characteristics, Outcomes, and Severity Risk Factors Associated with SARS-CoV-2 Infection among Children in the US National COVID Cohort Collaborative. JAMA Netw Open. 2022; 49. Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021 Oct 1;22(10):1416–26. 50. Sousa BLA, Sampaio-Carneiro M, de Carvalho WB, Silva CA, Ferraro AA. Differences among Severe Cases of Sars-CoV-2, Influenza, and Other Respiratory Viral Infections in Pediatric Patients: Symptoms, Outcomes and Preexisting Comorbidities. Clinics (Sao Paulo). 2020;75:e2273. 51. Swann O V., Pollock L, Holden KA, Munro APS, Bennett A, Williams TC, et al. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves. Pediatr Res. 2023 Jan 1;93(1):207–16. 52. Tripathi S, Christison AL, Levy E, McGravery J, Tekin A, Bolliger D, et al. The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19. Hosp Pediatr. 2021 Nov 1;11(11):E297–307. 53. Choudhary R, Webber BJ, Womack LS, Dupont HK, Chiu SK, Wanga V, et al. Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19. Hosp Pediatr. 2022 Sep 1;12(9):760–71. 54. Farrar Mph DS, Hepburn CM, Drouin Mdcm O, El Tal T, Morin MP, Berard RA, et al. COVID-19 AND MIS-C HOSPITALIZATIONS IN CANADA 1 Demographic and Outcome Characteristics of Children Hospitalized with Acute COVID-19 versus Multisystem Inflammatory Syndrome in Children in Canada. Available from: https://doi.org/10.1101/2022.08.18.22278939 55. Fink EL, Robertson CL, Wainwright MS, Roa JD, Lovett ME, Stulce C, et al. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022 Mar 1;128:33–44. 56. Forrest CB, Burrows EK, Mejias A, Razzaghi H, Christakis D, Jhaveri R, et al. Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021. Pediatrics. 2022 Apr 1;149(4). 57. Prévost B, Retbi A, Binder-Foucard F, Borde A, Bruandet A, Corvol H, et al. Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France. 2022; Available from: https://hal.inria.fr/hal-03774138 58. Rao S, Jing N, Liu X, Lorman V, Maltenfort M, Schuchard J, et al. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-1 based cohort study from the RECOVER program 2 3. Available from: https://doi.org/10.1101/2022.09.26.22280364Rhedin S, Lundholm C, Horne A, Smew AI, Osvald EC, Haddadi A, et al. Risk factors for multisystem inflammatory syndrome in children − A population-based cohort study of over 2 million children. 2022; Available from: https://doi.org/10.1016/j. 60. Ward JL, Harwood R, Smith C, Kenny S, Clark M, Davis PJ, et al. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med. 2022 Jan 1;28(1):193–200. 61. OMS. Organización Mundial de la Salud. “Vigilancia de salud pública en relación con la COVID-19, orientaciones provisionales, 16 de diciembre de 2020” [Internet]. Ginebra; 2020. p. 1–12. Available from: https://apps.who.int/iris/bitstream/handle/10665/338331/WHO-2019-nCoVSurveillanceGuidance-2020.8-spa.pdf 62. Choi JH, Choi SH, Yun KW. Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis. J Korean Med Sci. 2022;37(5). 63. Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q, et al. Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021;41. 64. Bailey LC. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatr. 2020 Feb 1;175(2):176– 84. 65. Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020 Sep 1;4(9):653–61. 66. Uka A, Buettcher M, Bernhard-Stirnemann S, Fougère Y, Moussaoui D, Kottanattu L, et al. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study. Eur J Pediatr. 2022;181(3). 67. Preston LE, Chevinsky JR, Kompaniyets L, Lavery AM, Kimball A, Boehmer TK, et al. Characteristics and Disease Severity of US Children and Adolescents Diagnosed with COVID-19. JAMA Netw Open. 2021;4(4). 68. Huang SM, Wu CH, Yen TY, Wu ET, Wang CC, Lu FL, et al. Clinical characteristics and factors associated with severe COVID-19 in hospitalized children during the SARS-CoV-2 Omicron pandemic in Taiwan. Journal of Microbiology, Immunology and Infection. 2023; 69. Schober T, Caya C, Barton M, Bayliss A, Bitnun A, Bowes J, et al. Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalised children. BMJ Paediatr Open. 2022;6(1). 70. Chao JY, Derespina KR, Herold BC, Goldman DL, Aldrich M, Weingarten J, et al. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. Journal of Pediatrics. 2020;223.. Ouldali N, Yang DD, Madhi F, Levy M, Gaschignard J, Craiu I, et al. Factors associated with severe SARS-CoV-2 infection. Pediatrics. 2021;147(3). 72. Wang Y, Zhu F, Wang C, Wu J, Liu J, Chen X, et al. Children Hospitalized With Severe COVID-19 in Wuhan. Pediatric Infectious Disease Journal. 2020;39(7). 73. Antoon JW, Grijalva CG, Thurm C, Richardson T, Spaulding AB, Ronald J Teufel II, et al. Factors Associated With COVID-19 Disease Severity in US Children and Adolescents. J Hosp Med. 2021;16(10). 74. Aparicio C. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and MetaAnalysis. medRxiv [Preprint]. 2024; 75. Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases [Internet]. 2021;103:246–56. Available from: https://doi.org/10.1016/j.ijid.2020.11.163 76. Lampidi S. Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population. . Eur J Pediatr. 2024 Jan; 77. Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR, Patel MM, et al. Incidence of Multisystem Inflammatory Syndrome in Children among US Persons Infected with SARSCoV-2. JAMA Netw Open. 2021;4(6). 78. Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA - Journal of the American Medical Association. 2021;325(11). 79. Rayner DG, Gou D, Chen JZX, Zhu E, Lin VW, Fu N. Prognostic factors for multisystem inflammatory syndrome in children: A systematic review and meta‐analysis. Acta Paediatr. 2024 Jan 10;113(1):39–47. 80. Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z. Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents—a Live Systematic Review and Meta-analysis. Vol. 10, Current Pediatrics Reports. 2022. 81. Lee EH, Kepler KL, Geevarughese A, Paneth-Pollak R, Dorsinville MS, Ngai S, et al. Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome. JAMA Netw Open. 2020;3(11). 82. Lona-Reyes JC, Paredes-Casillas P, Sepúlveda-Marrón J, Barrón-Balderas A, Cruz-Revilla R, Meza-López C, et al. Association of comorbidities and symptomatic infection and multisystemic inflammatory syndrome due to SARS-CoV-2 in children. Revista Chilena de Infectologia. 2021;38(5). 83. Zambrano LD, Ly KN, Link-Gelles R, Newhams MM, Akande M, Wu MJ, et al. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatric Infectious Disease Journal. 2022;41(11).84. Auger N, Côté-Corriveau G, Kang H, Quach C, Lo E, Lee GE, et al. Multisystem inflammatory syndrome in 1.2 million children: longitudinal cohort study of risk factors. Pediatr Res. 2024;95(1). 85. AMM. Declaración de Helsinki. Principios éticos para las investigaciones médicas en seres humanos. 1964; Available from: https://www.wma.net/es/policies-post/declaracion-dehelsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/ 86. Gobierno de Colombia. Ministerio de Salud y Protección Social. Resolución 8430 de 1993. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION -8430-DE-1993.PDFPublicationORIGINALTRABAJO DE GRADO Riesgo covid niños.pdfTRABAJO DE GRADO Riesgo covid niños.pdfapplication/pdf2149180https://digitk.areandina.edu.co/bitstreams/bc067c8a-e752-428e-9442-722c96d43f50/download4e145d859c743fbe343a529bf5209b69MD51formato autorización uso (1).pdfformato autorización uso (1).pdfapplication/pdf215380https://digitk.areandina.edu.co/bitstreams/17eaf464-af83-4c3d-b3ee-efa03bcb10ac/download1c39b35beba7e70388cd838e99d73d9bMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-815543https://digitk.areandina.edu.co/bitstreams/6880f689-5c65-4442-a4b5-67bd7bc37c3d/download73a5432e0b76442b22b026844140d683MD53TEXTTRABAJO DE GRADO Riesgo covid niños.pdf.txtTRABAJO DE GRADO Riesgo covid niños.pdf.txtExtracted texttext/plain102006https://digitk.areandina.edu.co/bitstreams/be5866df-002c-471f-8d5a-2c7aef154d21/download2cc1235c6201572fe605a00e0af2773aMD54formato autorización uso (1).pdf.txtformato autorización uso (1).pdf.txtExtracted texttext/plain7528https://digitk.areandina.edu.co/bitstreams/97b99bda-e013-4f19-9831-89c20dab1e40/download6108eeaa89a59c32ec0ddbb5ff94789bMD56THUMBNAILTRABAJO DE GRADO Riesgo covid niños.pdf.jpgTRABAJO DE GRADO Riesgo covid niños.pdf.jpgGenerated Thumbnailimage/jpeg6173https://digitk.areandina.edu.co/bitstreams/ea68d7aa-c1ee-4cf2-a515-513ecb92680d/download4f375c9fb1bf163feffcd1689278eadfMD55formato autorización uso (1).pdf.jpgformato autorización uso (1).pdf.jpgGenerated Thumbnailimage/jpeg14612https://digitk.areandina.edu.co/bitstreams/032b6458-18ea-4682-a384-0561aced4ba3/download015f682c8f750a2650e5e06dcf74fec1MD57areandina/6267oai:digitk.areandina.edu.co:areandina/62672025-04-25 14:23:23.563https://creativecommons.org/licenses/by-nc-nd/4.0/Texto general de licencia/copyright EL AUTOR-ESTUDIANTE, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto, la obra es de su exclusiva autoría y tiene la titularidad sobre la misma. PARÁGRAFO: en caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL ESTUDIANTE-AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la Fundación Universitaria del Área Andina actúa como un tercero de buena fe.open.accesshttps://digitk.areandina.edu.coAreandinabdigital@metabiblioteca.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

Publicaciones similares